Bliss GVS Pharma Limited has submitted to the Exchange a copy of the Scrutinizers' report of the Postal Ballot, along with the Voting Results.
BLISSGVS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bliss GVS Pharma has disclosed the voting results of a postal ballot that contained two special resolutions related to issuing sweat equity shares — one to Managing Director Gagan Harsh Sharma and another to Vice-President Vishal Vijay Rao. Voting took place from May 13 to June 11, 2025, with 50,199 shareholders on record. Both resolutions failed: Resolution 1 received 70.87% in favour (1,97,44,114 votes) and 29.13% against (81,15,451 votes), while Resolution 2 received 70.90% in favour (1,97,53,773 votes) and 29.10% against (81,05,792 votes). Since special resolutions require at least 75% approval under the Companies Act, both were rejected despite the majority voting in favour. Promoters and promoter group (holding 3,71,87,174 shares, or about 35% of total shares) abstained from voting as they were interested parties, which likely tipped the outcome against the proposals.
The failure of both special resolutions means Bliss GVS Pharma cannot issue sweat equity shares to its MD and VP under these proposals. This reflects meaningful shareholder dissent from management compensation plans and may lead the board to revise or re-table the incentive structure. In the short term, this is a negative signal for management credibility and could pressure the stock.